VOLPI, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 48.943
AS - Asia 21.348
EU - Europa 20.846
SA - Sud America 2.795
Continente sconosciuto - Info sul continente non disponibili 478
AF - Africa 451
OC - Oceania 104
Totale 94.965
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 47.937
SG - Singapore 6.512
GB - Regno Unito 6.300
CN - Cina 5.621
IT - Italia 4.311
SE - Svezia 3.379
HK - Hong Kong 2.395
BR - Brasile 2.079
VN - Vietnam 1.870
DE - Germania 1.329
FI - Finlandia 1.098
BD - Bangladesh 1.033
UA - Ucraina 1.016
KR - Corea 927
TR - Turchia 891
FR - Francia 888
RU - Federazione Russa 696
CA - Canada 498
IN - India 455
BG - Bulgaria 403
ID - Indonesia 285
NL - Olanda 235
MX - Messico 232
JP - Giappone 230
AR - Argentina 228
PL - Polonia 174
ES - Italia 161
IQ - Iraq 139
PK - Pakistan 133
ZA - Sudafrica 113
IE - Irlanda 110
CH - Svizzera 108
CO - Colombia 102
CL - Cile 97
AE - Emirati Arabi Uniti 93
MY - Malesia 91
AU - Australia 82
EC - Ecuador 82
TH - Thailandia 81
IR - Iran 77
VE - Venezuela 72
BE - Belgio 65
PE - Perù 62
MA - Marocco 61
LT - Lituania 59
RO - Romania 58
EG - Egitto 56
AT - Austria 55
CR - Costa Rica 55
GR - Grecia 54
PH - Filippine 54
UZ - Uzbekistan 54
DZ - Algeria 51
SA - Arabia Saudita 50
TN - Tunisia 48
IL - Israele 45
CZ - Repubblica Ceca 42
JM - Giamaica 41
PT - Portogallo 41
RS - Serbia 40
TW - Taiwan 40
NP - Nepal 39
SK - Slovacchia (Repubblica Slovacca) 39
KE - Kenya 37
JO - Giordania 36
DK - Danimarca 35
PY - Paraguay 26
EU - Europa 25
HN - Honduras 25
TT - Trinidad e Tobago 24
BO - Bolivia 23
KZ - Kazakistan 23
QA - Qatar 23
UY - Uruguay 22
AZ - Azerbaigian 21
EE - Estonia 21
HU - Ungheria 21
NZ - Nuova Zelanda 21
PR - Porto Rico 19
LB - Libano 17
GT - Guatemala 16
NI - Nicaragua 16
SV - El Salvador 16
AL - Albania 15
BH - Bahrain 15
HR - Croazia 15
NG - Nigeria 15
NO - Norvegia 15
SI - Slovenia 15
OM - Oman 14
BY - Bielorussia 13
DO - Repubblica Dominicana 12
ET - Etiopia 12
MD - Moldavia 11
SY - Repubblica araba siriana 11
PS - Palestinian Territory 10
GE - Georgia 9
KG - Kirghizistan 9
PA - Panama 9
AM - Armenia 8
Totale 94.347
Salva come PNG Salva come JPEG
Città #
Ashburn 6.613
Singapore 4.495
Southend 4.419
Santa Clara 3.693
Fairfield 3.406
Woodbridge 2.608
Hong Kong 2.333
Chandler 2.102
Houston 2.087
Jacksonville 2.011
Hefei 1.884
Stockholm 1.813
San Jose 1.780
Council Bluffs 1.608
Dearborn 1.557
Seattle 1.239
Wilmington 1.234
Ann Arbor 1.189
Beijing 1.170
Cambridge 1.113
London 965
Nyköping 950
Los Angeles 738
Helsinki 722
Seoul 655
The Dalles 594
New York 580
Ho Chi Minh City 579
Milan 474
Hanoi 473
Modena 462
Chicago 434
Princeton 416
Sofia 380
Izmir 370
Eugene 357
Buffalo 353
San Diego 345
Lauterbourg 308
Columbus 259
São Paulo 243
Dallas 234
Rome 228
Redwood City 221
Moscow 215
Jakarta 169
Shanghai 163
Salt Lake City 155
Toronto 146
Atlanta 139
Tokyo 136
Naples 133
Des Moines 127
Orem 120
Phoenix 112
Bologna 107
Frankfurt am Main 102
Falkenstein 94
Munich 92
Brooklyn 91
Dublin 89
Amsterdam 86
Boardman 86
Falls Church 85
Mexico City 82
Tampa 82
Haiphong 81
Dong Ket 80
Da Nang 77
San Francisco 76
Guangzhou 69
Chennai 68
Paris 68
Istanbul 67
Rio de Janeiro 67
Florence 66
Kent 65
Warsaw 64
Elk Grove Village 63
Lansdowne 63
Miano 63
Turin 62
Boston 61
Philadelphia 61
Norfolk 60
Norwalk 60
Montreal 59
Belo Horizonte 58
Denver 55
Lesquin 55
Nanjing 55
Turku 54
Madrid 52
Baghdad 51
Brussels 50
Bangkok 48
Miami 46
Kunming 45
Saint Augustine 45
Nuremberg 44
Totale 64.363
Salva come PNG Salva come JPEG
Nome #
Adenylate pool and energy charge in human lymphocytes and granulocytes irradiated at 632 nm (HeNe Laser) 1.983
Oral bioavailability and pharmacokinetic of non-animal chondroitin sulfate and its constituents in healthy male volunteers 1.896
BIOCHIMICA STRUTTURALE, FUNZIONALE E METABOLICA 1.315
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 749
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 744
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 649
A 96-well assay for uronic acid carbazole reaction 645
Two analytical approaches to the evaluation of chondroitin sulfate in european food supplements. 644
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 524
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 498
Shockwave lithotripsy and the protective role of inosine: Early and late evaluation in an experimental model 443
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 424
Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum 410
Chondroitin sulfate. Structure, role and pharmacological activity. Nicola Volpi (Editor) 404
Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs). 390
Capillary blotting of glycosaminoglycans on nitrocellulose membranes after agarose-gel electrophoresis separation 387
Beta-amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. 385
Oral bioavailability of chondroitin sulfate (Condrosulf (R)) and its constituents in healthy male volunteers 380
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) 377
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 375
Comparison of CPC and CETAB extractive procedures for quantification and characterization of human urinary glycosaminoglycans 373
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 370
Analytical aspects of pharmaceutical grade chondroitin sulfates 369
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 366
12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. 365
Plasmatic and urinary glycosaminoglycans characterization in mucopolysaccharidosis II Patient treated with enzyme-replacement therapy with Idursulfase 364
Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers 364
activity of chondroitin ABC lyase on dermatan sulfate partially degraded by cupric-ion-mediated free-radical treatment 363
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 361
Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry 359
Comparative analysis of fatty acid profile in three eutardigrade species 359
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 357
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 357
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 349
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 347
Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis 343
effects of glycosaminoglycans on u-937 leukemia-cell proliferation and differentiation - structure-function relationship 340
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 339
Electrophoretic approaches to the analysis of complex polysaccharides 337
Shift of optimal pH in arylsulphatase from Mollusca depending on temperature 337
Analysis of glycosaminoglycan-derived, pre-column 2-aminoacridone-labeled disaccharides using liquid chromatography-fluorescence and -mass spectrometric detection. 337
Adsorption of glycosaminoglycans onto coral - a new possible implant biomaterials for regeneration therapy 336
Purification and characterization of heparin from the Italian clam Callista chione 330
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model 329
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 328
Chondroitin sulfate in normal human plasma is modified depending on the age. Its evaluation in patients with pseudoxanthoma elasticum 327
Glycosaminoglycan Blotting and Detection After Electrophoresis Separation 327
Purification and characterization of hyaluronic acid from the mollusc bivalve Mytilus galloprovincialis 326
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 325
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 325
Pharmacokinetics of chondroitin sulfate 325
Glycosaminoglycan composition of the large freshwater mollusc bivalve Anodonta anodonta 322
Therapeutic applications of glycosaminoglycans 322
Recent advances on separation and characterization of human milk oligosaccharides. 321
Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations 320
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 318
Glycosaminoglycan content in term and preterm milk during the first month of lactation 318
EFFECTS OF LOW-POWER 632 NM RADIATION (HENE LASER) ON A HUMAN CELL-LINE - INFLUENCE ON ADENYLNUCLEOTIDES AND CYTOSKELETAL STRUCTURES 317
Quantitative and Qualitative Evaluation of ChondroitinSulfate in Dietary Supplements 317
Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). 317
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 316
Capillary electrophoresis of bacterial (lipo)polysaccharides 315
Composition and structure elucidation of human milk glycosaminoglycans 314
Le arilsolfatasi come glicoconiugati: aspetti biochimico - comparati della loro regolazione 314
The protein profile of fibroblasts: the role of proteomics. 314
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 313
Isolation and structural characterization of chondroitin sulfate from bony fishes 313
Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability. 313
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 312
Determination of urinary hexosamines for diagnosis of bladder pain syndrome 309
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 308
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease. 306
Activity of chondroitin ABC lyase and hyaluronidase on free-radical degraded chondroitin sulfate 306
Different analyses measure chondroitin pharmacokinetics. 304
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All 302
Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever 301
Advances in chondroitin sulfate analysis: Application in physiological and pathological states of connective tissue and during pharmacological treatment of osteoarthritis 301
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced by Streptomyces hyalurolyticus hyaluronate lyase 300
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 299
1H and 13C Characterization of Chondroitin Sulphate from Porcine Trachea and Shark Cartilage 297
Human Milk Glycosaminoglycans Inhibit in vitro the Adhesion of Escherichia coli and Salmonella fyris to Human Intestinal Cells 296
Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate 296
Approccio globale alle mucopolisaccaridosi: applicazione di metodi altamente specifici per la diagnosi neonatale: risultati preliminari su campione di urina 296
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 296
Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations 295
Role, metabolism, chemical modifications and applications of hyaluronan 295
1H and 13C Characterization of Chondroitin Sulphate from Beef Trachea 294
Capillary electrophoresis of complex natural polysaccharides 294
Electrophoresis for the analysis of heparin purity and quality. 293
effect of low-frequency electromagnetic pulsed-field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 292
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 292
Capillary electrophoresis of Biomolecules. Methods and Protocols. 292
Influence of charge density, sulfate group position and molecular mass on adsorption of chondroitin sulfate onto coral 291
Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects 290
IMPLICANCIA DE LAS CADENAS DE GLICOSAMINOGLICANOS DE LA MATRIZ EXTRACELULAR EN LA “ATERO-RESISTENCIA” VASCULAR. 289
Human milk glycosaminoglycans: the state of the art and future perspectives 288
Mass spectrometry characterization of Escherichia coli K4 oligosaccharides from 2-mers to more than 20-mers 287
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes 286
Glycosaminoglycan profiling as a novel pan-cancer minimally invasive systems biomarker. 285
Characterization of a low-sulfated chondroitin sulfate isolated from the hemolymph of the freshwater snail Planorbarius corneus 284
Totale 39.216
Salva come PNG Salva come JPEG
Categoria #
all - tutte 332.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 332.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.154 0 0 0 425 158 312 312 251 718 462 801 715
2022/20236.174 692 581 425 543 684 905 183 688 819 74 285 295
2023/20244.542 227 281 197 571 1.042 351 394 584 128 134 213 420
2024/202513.778 518 194 225 969 2.501 1.889 773 1.092 1.542 898 1.500 1.677
2025/202627.362 1.406 968 2.446 2.445 3.430 2.160 3.074 1.515 4.153 2.267 1.832 1.666
2026/202710.532 2.450 1.731 2.933 3.418 0 0 0 0 0 0 0 0
Totale 94.965